Virginie Gardette - Publications

Affiliations: 
Toulouse 3 

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Clarke L, Castor-Newton MJ, Angénieux O, Lapeyre-Mestre M, Gardette V. [Not Available]. Sante Publique (Vandoeuvre-Les-Nancy, France). 34: 695-707. PMID 36577668 DOI: 10.3917/spub.225.0695  0.442
2022 Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V. Healthcare use patterns before Alzheimer's disease and related diseases identification and future healthcare trajectory. International Journal of Geriatric Psychiatry. 38: e5849. PMID 36457190 DOI: 10.1002/gps.5849  0.495
2022 Villars H, Gardette V, Frayssignes P, Deperetti E, Perrin A, Cantet C, Soto-Martin M. Predictors of nursing home placement at 2 years in Alzheimer's disease: A follow-up survey from the THERAD study. International Journal of Geriatric Psychiatry. 37. PMID 35574920 DOI: 10.1002/gps.5724  0.321
2021 Gallini A, Jegou D, Lapeyre-Mestre M, Couret A, Bourrel R, Ousset PJ, Fabre D, Andrieu S, Gardette V. Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data. Current Alzheimer Research. PMID 33882802 DOI: 10.2174/1567205018666210416094639  0.615
2020 Poncet M, Gardette V, Couret A, Renoux A, Lapeyre-Mestre M, Gallini A. Benzodiazepine exposure in subjects with incident Alzheimer's disease and related syndromes in France: a longitudinal study 2011-2017. International Clinical Psychopharmacology. PMID 32324610 DOI: 10.1097/Yic.0000000000000312  0.563
2020 Couret A, Gallini A, Poncet M, Renoux A, Lapeyre-Mestre M, Gardette V. Benzodiazepine Dispensing to Persons With Dementia in France, 2011-2016: A Nationwide Study. Journal of the American Medical Directors Association. PMID 32299715 DOI: 10.1016/J.Jamda.2020.02.019  0.583
2020 Gombault-Datzenko E, Gallini A, Carcaillon-Bentata L, Fabre D, Nourhashemi F, Andrieu S, Rachas A, Gardette V. Alzheimer's Disease and Related Syndromes and hospitalization: a nationwide 5-year longitudinal study. European Journal of Neurology. PMID 32285533 DOI: 10.1111/Ene.14256  0.57
2020 Escourrou E, Durrieu F, Chicoulaa B, Dupouy J, Oustric S, Andrieu S, Gardette V. Cognitive, functional, physical, and nutritional status of the oldest old encountered in primary care: a systematic review. Bmc Family Practice. 21: 58. PMID 32220228 DOI: 10.1186/S12875-020-01128-7  0.693
2019 Andre L, Gallini A, Montastruc F, Montastruc JL, Piau A, Lapeyre-Mestre M, Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. European Journal of Clinical Pharmacology. PMID 31468067 DOI: 10.1007/S00228-019-02744-8  0.492
2019 Rachas A, Gallini A, Gombault E, Carcaillon-Bentata L, Gardette V, Gastaldi-Ménager Ch. Use of medical care in the 7 years before dementia in the French health insurance database in 2016 European Journal of Public Health. 29. DOI: 10.1093/Eurpub/Ckz187.215  0.395
2018 Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V. Anticholinergic exposure and cognitive decline in older adults: Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study. British Journal of Clinical Pharmacology. PMID 30098049 DOI: 10.1111/Bcp.13734  0.691
2018 Wargny M, Gallini A, Hanaire H, Nourhashemi F, Andrieu S, Gardette V. Diabetes Care and Dementia Among Older Adults: A Nationwide 3-Year Longitudinal Study. Journal of the American Medical Directors Association. PMID 29396187 DOI: 10.1016/J.Jamda.2017.12.006  0.531
2017 Gallini A, Moisan F, Maura G, Carcaillon-Bentata L, Leray E, Haesebaert J, Bruandet A, Moutengou E, Luciano L, Weill A, Marin B, Gardette V. [Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature]. Revue D'Epidemiologie Et De Sante Publique. PMID 28341166 DOI: 10.1016/J.Respe.2017.01.115  0.36
2017 Gallini A, Coley N, Andrieu S, Lapeyre-Mestre M, Gardette V. Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012. Fundamental & Clinical Pharmacology. PMID 28258589 DOI: 10.1111/Fcp.12281  0.727
2015 Coley N, Gallini A, Garès V, Gardette V, Andrieu S. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. Journal of the American Medical Directors Association. 16: 1104.e1-7. PMID 26593306 DOI: 10.1016/J.Jamda.2015.09.010  0.724
2015 Gallini A, Gardette V, Lapeyre-Mestre M, De Souto Barreto P, Vellas B, Andrieu S, Rolland Y. Dementia diagnosis and influenza vaccination in French nursing home residents Journal of the American Geriatrics Society. 63: 1256-1258. PMID 26096405 DOI: 10.1111/Jgs.13515  0.591
2015 Montastruc F, Rouanet S, Gardette V, Rousseau V, Bagheri H, Montastruc JL. Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database. European Journal of Clinical Pharmacology. 71: 891-5. PMID 25991052 DOI: 10.1007/S00228-015-1869-0  0.392
2015 Gallini A, Gardette V, Oumouhou N, Andrieu S, Donohue JM. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010. Psychiatric Services (Washington, D.C.). 66: 434-7. PMID 25588416 DOI: 10.1176/Appi.Ps.201400020  0.468
2015 Coley N, Garès V, Vellas B, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Boada M, Dartigues JF, Olde-Rikkert MGM, Rigaud AS, Winblad B, Malick A, Frölich L, ... ... Gardette V, et al. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort Journal of the American Medical Directors Association. 16: 1104.e1-1104.e7. DOI: 10.1016/j.jamda.2015.09.010  0.693
2014 Villars H, Gardette V, Perrin A, Hein C, Elmalem S, de Peretti E, Zueras A, Vellas B, Nourhashémi F. Study protocol: Randomised controlled trial to evaluate the impact of an educational programme on Alzheimer's disease patients' quality of life. Alzheimer's Research & Therapy. 6: 66. PMID 25478028 DOI: 10.1186/S13195-014-0066-1  0.365
2014 Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. Cns Drugs. 28: 157-70. PMID 24408842 DOI: 10.1007/S40263-013-0133-3  0.649
2014 Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 95-104. PMID 24126116 DOI: 10.1016/J.Euroneuro.2013.09.003  0.644
2014 Gallini A, Gardette V, Lapeyre-Mestreb M, Andrieu S. Effet de la démence sur le recours à la vaccination contre la grippe saisonnière chez les personnes âgées : une analyse dans l’échantillon généralisé de bénéficiaires Revue D'éPidéMiologie Et De Santé Publique. 62: S122-S123. DOI: 10.1016/J.Respe.2014.05.023  0.488
2014 Gallini A, Gardette V, Lapeyre-Mestre M, Andrieu S. Recours à la vaccination contre la grippe saisonnière chez les personnes âgées : effet de la démence Revue D'éPidéMiologie Et De Santé Publique. 62: S82-S83. DOI: 10.1016/J.Respe.2014.01.037  0.58
2013 Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! European Journal of Clinical Pharmacology. 69: 1589-97. PMID 23588564 DOI: 10.1007/S00228-013-1506-8  0.68
2013 Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C. Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease. Drugs & Aging. 30: 439-45. PMID 23512718 DOI: 10.1007/S40266-013-0070-3  0.68
2013 Villars H, Dupuy C, Soler P, Gardette V, Soto ME, Gillette S, Nourhashemi F, Vellas B. A follow-up intervention in severely demented patients after discharge from a special Alzheimer acute care unit: impact on early emergency room re-hospitalization rate. International Journal of Geriatric Psychiatry. 28: 1131-40. PMID 23348897 DOI: 10.1002/Gps.3932  0.385
2012 Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. Current Alzheimer Research. 9: 1106-16. PMID 22950915 DOI: 10.2174/156720512803569037  0.747
2012 Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Agüera-Morales E, Auriacombe S, Boada M, Bullock R, Byrne J, Camus V, Cherubini A, Eriksdotter-Jönhagen M, et al. Progression of Alzheimer disease in Europe: data from the European ICTUS study. Current Alzheimer Research. 9: 902-12. PMID 22742853 DOI: 10.2174/156720512803251066  0.597
2012 Andrieu S, Coley N, Gardette V, Subra J, Oustric S, Fournier T, Poulain JP, Coniasse-Brioude D, Igier V, Vellas B, Grand A. Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer's disease (ACCEPT study)--the need for a multidisciplinary approach. The Journal of Nutrition, Health & Aging. 16: 352-4. PMID 22499457 DOI: 10.1007/S12603-012-0045-9  0.7
2012 Soto ME, Andrieu S, Villars H, Secher M, Gardette V, Coley N, Nourhashemi F, Vellas B. Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unit. Journal of the American Medical Directors Association. 13: 486.e1-6. PMID 22264688 DOI: 10.1016/J.Jamda.2011.12.058  0.703
2012 Abellan van Kan G, Rolland Y, Gillette-Guyonnet S, Gardette V, Annweiler C, Beauchet O, Andrieu S, Vellas B. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 425-32. PMID 21975092 DOI: 10.1093/Gerona/Glr177  0.524
2012 Vellas B, Hausner L, Cantet I, Gardette V, Reynish E, Gillette S, Ousset P, Froelich L, Winblad B, Andrieu S. Obesity impairs ADL and IADL in Alzheimer's disease subjects Alzheimers & Dementia. 8: 324. DOI: 10.1016/J.Jalz.2012.05.897  0.34
2011 Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 579-92. PMID 22055975 DOI: 10.1016/J.Jalz.2011.02.009  0.75
2011 Arbus C, Gardette V, Cantet CE, Andrieu S, Nourhashémi F, Schmitt L, Vellas B. Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study. The Journal of Nutrition, Health & Aging. 15: 609-17. PMID 21968854 DOI: 10.1007/S12603-011-0061-1  0.552
2011 Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Current Alzheimer Research. 8: 421-33. PMID 21244348 DOI: 10.2174/156720511795745339  0.723
2011 Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How Should We Deal with Missing Data in Clinical Trials Involving Alzheimer's Disease Patients? Current Alzheimer Research. 999: 1-12. DOI: 10.2174/1567211212443482050  0.7
2010 Hausner L, Frölich L, Gardette V, Reynish E, Ousset PJ, Andrieu S, Vellas B, On Behalf Of The Ictus-Eadc Study Group. Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: data from the ICTUS study. Journal of Alzheimer's Disease : Jad. 21: 155-65. PMID 20413884 DOI: 10.3233/Jad-2010-091489  0.572
2010 Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. Cns Drugs. 24: 431-42. PMID 20369907 DOI: 10.2165/11318010-000000000-00000  0.744
2010 Arbus C, Gardette V, Bui E, Cantet C, Andrieu S, Nourhashémi F, Schmitt L, Vellas B. Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort. International Psychogeriatrics / Ipa. 22: 120-8. PMID 19735591 DOI: 10.1017/S1041610209990780  0.61
2009 Gillioz AS, Villars H, Voisin T, Cortes F, Gillette-Guyonnet S, Andrieu S, Gardette V, Nourhashémi F, Ousset PJ, Jouanny P, Vellas B. Spared and impaired abilities in community-dwelling patients entering the severe stage of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 28: 427-32. PMID 19907179 DOI: 10.1159/000255635  0.593
2009 Gardette V, Bongard V, Dallongeville J, Arveiler D, Bingham A, Ruidavets JB, Amouyel P, Haas B, Ducimetière P, Ferrières J. Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort). The American Journal of Cardiology. 103: 381-6. PMID 19166693 DOI: 10.1016/J.Amjcard.2008.09.092  0.322
2009 Gardette V, Cestac P, Cantet C, Reynish E, Lapeyre-Mestre M, Andrieu S, Vellas B. Comparaison européenne de la prescription de médicaments spécifiques antidémentiels : l’étude ICTUS Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.003  0.579
2009 Gardette V, Cestac P, Andrieu S, Cantet C, Montastruc J, Nourhashemi F, Lapeyre-Mestre M, Vellas B. Profil d’utilisation des médicaments spécifiques antidémentiels et des psychotropes dans la maladie d’Alzheimer : l’étude Plasa Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.002  0.569
2008 Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, Grand A. Dementia prevention: methodological explanations for inconsistent results. Epidemiologic Reviews. 30: 35-66. PMID 18779228 DOI: 10.1093/Epirev/Mxn010  0.709
2008 Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B. Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study. Neuroepidemiology. 31: 69-79. PMID 18622142 DOI: 10.1159/000144087  0.732
2008 Gardette V, Andrieu S, Gillette-Guyonnet S, Nourhashémi F, Ousset PJ, Cantet C, Lapeyre-Mestre M, Montastruc J, Vellas B. P2-392: Predictive factors of discontinuation and switch of cholinesterase inhibitors in Alzheimer's disease Alzheimer's & Dementia. 4: T488-T488. DOI: 10.1016/J.Jalz.2008.05.1470  0.637
2006 Roussin A, Mirepoix M, Lassabe G, Dumestre-Toulet V, Gardette V, Montastruc JL, Lapeyre-Mestre M. Death related to a recreational abuse of propofol at therapeutic dose range. British Journal of Anaesthesia. 97: 268. PMID 16831883 DOI: 10.1093/BJA/AEL168  0.341
Show low-probability matches.